Alcohol addiction or alcohol abuse increases the likelihood of developing co-occurring conditions, such as substance use disorders. Often, the mixing of alcohol and other drugs together can lead to serious physical, behavioral, and health complications. These disorders should not be self-treated. The symptoms of addiction are observed in the entire body, affecting the brain, heart, pancreas, mouth, liver, and immune system.
One of the more insightful recent statistics on alcohol addiction states that there are more than 80,000 alcohol-related deaths each year in the United States, according to the National Institute on Alcohol Abuse and Alcoholism (NIAAA), 2018. In most societies, presently, the intake of alcohol has considerably increased among women. Benzodiazepines are most commonly used in the market and are used for several clinical trial studies. In the pipeline, several molecular mechanism-based drugs have emerged, and are presently being studied in preclinical trials. Significant efforts are being made to curb substance abuse, which increases the pipeline drugs for alcohol addiction.
This report by Mordor Intelligence provides extensive insights into the current scenario and growth prospects of the market studied. Detailed graphical representations of the pipeline landscape, based on various phases, and the status of clinical trials, across major regions of the world, are given, with data obtained from multiple sources. The report also comprises a list of key sponsors that have pipeline products for the concerned market.
The report will cover analysis on trails and information on key sponsors, companies and researchers.
Our data collection team builds scientific research models, based on data sourced from various internal databases, primary and secondary researches, and our in-house team of research experts. The pipeline assessment reports are generated based on information procured from various stake holders, such as sponsors, clinical trial organizations, pharmaceutical companies, government bodies, trade agencies, industry journals, scientific literature databases, investor reports, press release statements, and several other sources. The data generated using secondary research and primary research is validated through discussions with industry KOL’s and C-suite executives. The data presented in the reports is continuously updated to incorporate the most relevant and authentic information to our clients.
2. Research Methodology
3. Disease Epidemiology and Trends
4. Healthcare Expenditure and R&D Trends
5. Executive Summary
6. Clinical Trials Segmentation by Phase
6.1 Phase-III Product Candidates
6.2 Phase-II Product Candidates
6.3 Phase-I Product Candidates
7. Clinical Trials, Segmentation by Status
8. Pipeline Therapeutic Assessment (Infographic Charts and a Brief Description)
8.1. By Clinical Phase and Molecule Type
8.2. By Clinical Phase and Route of Administration
8.3 By Sponsor/Collaborator/Institutions
8.4 By Geography
9. Market Updates
10. Key Sponsor Profiles
11. Sources and Disclaimer
12. About Mordor Intelligence